U.S. flag

An official website of the United States government

NC_000006.11:g.(135754395_135759512)_(135759637_135763719)del AND Joubert syndrome and related disorders

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 28, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002510450.1

Allele description [Variation Report for NC_000006.11:g.(135754395_135759512)_(135759637_135763719)del]

NC_000006.11:g.(135754395_135759512)_(135759637_135763719)del

Gene:
AHI1:Abelson helper integration site 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
6q23.3
Genomic location:
Chr6: 135754395 - 135763719 (on Assembly GRCh37)
Preferred name:
NC_000006.11:g.(135754395_135759512)_(135759637_135763719)del
HGVS:
NC_000006.11:g.(135754395_135759512)_(135759637_135763719)del

Condition(s)

Name:
Joubert syndrome and related disorders
Identifiers:
MONDO: MONDO:0015369; MedGen: C5679612

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002819872Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Dec 28, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease.

Carss KJ, Arno G, Erwood M, Stephens J, Sanchis-Juan A, Hull S, Megy K, Grozeva D, Dewhurst E, Malka S, Plagnol V, Penkett C, Stirrups K, Rizzo R, Wright G, Josifova D, Bitner-Glindzicz M, Scott RH, Clement E, Allen L, Armstrong R, Brady AF, et al.

Am J Hum Genet. 2017 Jan 5;100(1):75-90. doi: 10.1016/j.ajhg.2016.12.003. Epub 2016 Dec 29.

PubMed [citation]
PMID:
28041643
PMCID:
PMC5223092

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002819872.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: The variant identified by MLPA or other technology involves the deletion of exon 14 in the AHI1 gene. A presumed nomenclature of c.(1912+1_1913-1)_(2036+1_2037-1)del has been designated for the purposes of this classification. Although exact breakpoints of this deletion are not known, it is expected to result in a frameshift in the AHI1 gene, a known mechanism of disease. The variant was absent in 21694 control chromosomes. c.(1912+1_1913-1)_(2036+1_2037-1)del has been reported in the literature in at least one individual affected with retinal disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 4, 2023